(24) have reported that the specific CDK7 inhibitor THZ2 could suppress the phosphorylation of RNAPII CTD and selectively suppress super-enhancer-related genes, leading to anti-osteosarcoma effects. The gene discussed is CDK7; the disease is osteosarcoma.